Relationships of Adiponectin with Markers of Systemic Inflammation and Insulin Resistance in Infants Undergoing Open Cardiac Surgery
Background. Insulin resistance and systemic inflammation frequently occur in infants undergoing cardiac surgery with cardiopulmonary bypass, while adiponectin has been demonstrated to have insulin-sensitizing and anti-inflammatory properties in obesity and type 2 diabetes mellitus. In this prospecti...
Main Authors: | Yukun Cao, Ting Yang, Shiqiang Yu, Guocheng Sun, Chunhu Gu, Dinghua Yi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/187940 |
Similar Items
-
Postoperative Adiponectin Levels in Pediatric Patients Undergoing Open Heart Surgery
by: A. Thaler, et al.
Published: (2013-01-01) -
Medanta insulin protocols in patients undergoing cardiac surgery
by: Beena Bansal, et al.
Published: (2014-01-01) -
Cardioprotective effect of ghrelin in cardiopulmonary bypass involves a reduction in inflammatory response.
by: Yukun Cao, et al.
Published: (2013-01-01) -
Population pharmacokinetics of remifentanil in infants and children undergoing cardiac surgery
by: Hammer Gregory B, et al.
Published: (2009-07-01) -
Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study
by: Hjortdal Vibeke E, et al.
Published: (2010-12-01)